ALK-Abelló A/S
Save
5.30B
Market cap
51.74x
Current P/E
–
Forward P/E
About
Health care
Sector
Biotechnology
Industry
ALK-Abelló A/S operates as an allergy solutions company in Europe, North America, and internationally. The company offers allergy immunotherapy products in the form of injections, sublingual drops, and tablets for the treatment of various allergies, including house dust mite, grass, tree, ragweed, and Japanese cedar. It also provides adrenaline auto-injectors for the treatment of severe allergic reactions; and manufactures products used in the diagnosis of allergies.
Similar securities
Based on sector and market capitalization
Report issue